July 24, 2007. DeZnIt consortium starts.

Today the official start of the DeZnIt consortium is announced. DeZnIt stands for Design of zinc metalloenzyme targeted drugs using an Integrated Technology approach. The consortium aims at designing new classes of drugs against this very important class of enzymes. Read the Full Press release.

March 3, 2007. KeyDP participates in Opticryst consortium.

KeyDP participates in the European FP6 consortium Opticryst. The consortium will try to develop rational approaches for optimising the crystallisation of proteins, with the aim of improving the success of structural genomics initiatives. A full press release will follow soon

December 27, 2005. DEADBUGS consortium starts.

Today the official start of the DEADBUGS consortium is announced. DEADBUGS stands for DEsign of Antibacterial Drugs Based on Unexplored Genetic Structures . The consortium aims at designing new antibacterial drugs with broad spectrum of activity that target essential bacterial transcriptional regulators. Read the Full Press release.

Meet KeyDP and Formulatrix Europe at these upcoming events: